“Multi Domain-Protein” developed: Malaria vaccine from Germany is proven efficacious
Münster, Germany: In collaboration with the University of Edinburgh in Scotland the biotechnology firm CILIAN AG succeeded to reconstruct an important surface protein of the Malaria parasite. The uniqueness of this vaccine is that it is produced in ciliates and covers nearly all variations